| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/25/2012 | CN101244165B 一种治疗湿热淋证的片剂及其制备方法 A heat cream card tablets and its preparation method of treatment |
| 04/25/2012 | CN101217947B 包含壳聚糖和环糊精的纳米颗粒 Nanoparticles comprising chitosan and cyclodextrin |
| 04/25/2012 | CN101199615B 一种治疗口腔溃疡的外用内服口腔崩解片及其制备方法 A method of treating mouth ulcers topical oral orally disintegrating tablets and its preparation method |
| 04/25/2012 | CN101132778B 调节用于施用对水消毒剂敏感的药物或疫苗的水的水质的组合物 Conditioning compositions for administering water-sensitive drugs or vaccines disinfectant water quality of the water |
| 04/25/2012 | CN101040933B 维生素e的复合胶囊 Complex vitamin e capsules |
| 04/25/2012 | CN101032559B 益心健脾中成药的制备方法 Yixin spleen preparation of proprietary Chinese medicines |
| 04/24/2012 | US8163798 Administering methylphenidate at an ascending release rate over an extended time period; therapeutic affect over long time period; hyperactivity/attention deficit disorder |
| 04/24/2012 | US8163751 Acylated indanyl amines and their use as pharmaceuticals |
| 04/24/2012 | US8163723 Combination of azelastine and steroids |
| 04/24/2012 | US8163722 Pharmaceutical formulation for contraception and hormone-replacement therapy |
| 04/24/2012 | US8163714 Injectable crosslinked and uncrosslinked alginates and the use thereof in medicine and in cosmetic surgery |
| 04/24/2012 | US8163384 Antimicrobial composites, films, labelstocks and labels |
| 04/24/2012 | US8163312 Herbal formulation for prevention and treatment of diabetes and associated complications |
| 04/24/2012 | US8163307 Controlled release compositions for interferon based PEGT/PBT block copolymers and method for preparation thereof |
| 04/24/2012 | US8163306 Coated tablet; an active ingredient, excipient, a swellable composition and a reactive composition; a water insoluble polymer surrounding the core, and leachable component |
| 04/24/2012 | US8163305 Targeted cross-linked nanoparticles and their use in vivo gene delivery |
| 04/24/2012 | US8163299 Stabilized pharmaceutical product |
| 04/24/2012 | US8163298 Aqueous gel having an alpha-hydroxy acid and suspended particulates |
| 04/24/2012 | US8163271 Oral hygiene products and method of using the same |
| 04/24/2012 | US8162924 System, devices, and methods including actively-controllable superoxide water generating systems |
| 04/24/2012 | US8162923 Disposable infusion device with automatic unlocking mechanism |
| 04/24/2012 | CA2671383C Dried composition |
| 04/24/2012 | CA2655230C A process for manufacturing a delivery system for active components as part of an edible composition |
| 04/24/2012 | CA2641221C Method to predict and prevent oxygen-induced inflammatory tissue injury |
| 04/24/2012 | CA2539256C Targeted lipid-drug formulations for delivery of drugs to myeloid and lymphoid immune cells |
| 04/24/2012 | CA2534551C Cosmetic composition to assist transport of oxygen into the skin |
| 04/24/2012 | CA2472582C Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer |
| 04/24/2012 | CA2471418C Method of obtaining novel lutein-based formulations |
| 04/24/2012 | CA2466244C Methods and apparatus for production of a micro-organ |
| 04/24/2012 | CA2466036C Taste masking spill-resistant formulation |
| 04/24/2012 | CA2465132C Vaginally administered anti-dysrhythmic agents for treating pelvic pain |
| 04/24/2012 | CA2456601C Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
| 04/24/2012 | CA2447376C Prebiotic and probiotic compositions and methods for their use in gut-based therapies |
| 04/24/2012 | CA2439570C In-situ gel formation of pectins |
| 04/22/2012 | CA2745270A1 System and method for satellite drug delivery |
| 04/19/2012 | WO2012051488A1 Pharmaceutical compositions containing a dgat1 inhibitor |
| 04/19/2012 | WO2012051426A2 Aggregate nanoparticulate medicament formulations, manufacture and use thereof |
| 04/19/2012 | WO2012051416A1 Pharmaceutical formulation for histone deacetylase inhibitors |
| 04/19/2012 | WO2012051341A1 Hydrothermal process for enhanced stability of mesoporous nanoparticles |
| 04/19/2012 | WO2012051313A2 Ophthalmic formulations, methods of manufacture and methods of normalizing meibomian gland secretions |
| 04/19/2012 | WO2012051220A1 Composite magnetic nanoparticle drug delivery system |
| 04/19/2012 | WO2012051204A2 Antimicrobial formulations that aid in wound healing |
| 04/19/2012 | WO2012051035A1 Novel cellulose ethers and their use |
| 04/19/2012 | WO2012050945A1 Cationic dry powders |
| 04/19/2012 | WO2012050922A2 Gastric retentive dosage forms for extended release of acamprosate into the upper gastrointestinal tract |
| 04/19/2012 | WO2012050899A1 Polymer-agent conjugates, particles, compositions, and related methods of use |
| 04/19/2012 | WO2012050896A2 Protease selective supramolecular assemblies |
| 04/19/2012 | WO2012050810A2 Shape-controlled magnetic nanoparticles as t1 contrast agents for magnetic resonance imaging |
| 04/19/2012 | WO2012050735A1 Methods and dosage forms for the treatment of human cancers |
| 04/19/2012 | WO2012050539A1 Pharmaceutical composition comprising eplerenone |
| 04/19/2012 | WO2012050359A2 Hydrogel particle coated with lipid and method for manufacturing same |
| 04/19/2012 | WO2012050193A1 Ebola virus liposome vaccine |
| 04/19/2012 | WO2012050184A1 Sustained-release pharmaceutical composition |
| 04/19/2012 | WO2012049676A2 Apparatuses and methods of intravaginal support and/or distension |
| 04/19/2012 | WO2012049642A1 A sieving method for cetyl myristate and/or cetyl palmitate |
| 04/19/2012 | WO2012049641A1 Use of disintegrants in cetyl myristate and/or cetyl palmitate formulations |
| 04/19/2012 | WO2012049640A1 Coating of cetyl myristate and/or cetyl palmitate particles |
| 04/19/2012 | WO2012049639A1 Formulations of cetyl myristate and/or cetyl palmitate |
| 04/19/2012 | WO2012049550A1 Liquid pharmaceutical composition for pain treatment and prevention |
| 04/19/2012 | WO2012049545A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it |
| 04/19/2012 | WO2012049544A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, a hydrocortisone acetate as a corticosteroid, and clotrimazole as an antifungal agent, and a process to make it |
| 04/19/2012 | WO2012049543A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it |
| 04/19/2012 | WO2012049542A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer, mometasone as a corticosteroid and clotrimazol as antifungal agent, and a process to make it |
| 04/19/2012 | WO2012049541A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a corticosteroid, and a process to make it |
| 04/19/2012 | WO2012049540A1 A medicinal fusidic acid cream made using sodium fusidate, a corticosteroid, and an antifungal agent, and incorporating a biopolymer, and a process to make it |
| 04/19/2012 | WO2012049539A1 A medicinal fusidic acid cream made using sodium fusidate, a corticosteroid, and an antifungal agent, and incorporating a biopolymer, and a process to make it |
| 04/19/2012 | WO2012049488A1 Surfactant vesicles |
| 04/19/2012 | WO2012049444A1 Pharmaceutical composition |
| 04/19/2012 | WO2012049159A1 Composition for treating cancer by the controlled release of an active substance |
| 04/19/2012 | WO2012049156A1 Non-starch based soft chewables |
| 04/19/2012 | WO2012048914A1 Suction device |
| 04/19/2012 | WO2012048854A2 Formulation suitable for stabilizing proteins, which is free of mammalian excipients |
| 04/19/2012 | WO2012048846A2 Phosphate binder formulation for simple ingestion |
| 04/19/2012 | WO2012048455A1 Transdermal absorption patch of antiviral drug and its preparation method |
| 04/19/2012 | WO2012017385A3 Beclomethasone dipropionate compositions in modified-release gastro-resistant microspheres and process for obtaining them |
| 04/19/2012 | WO2012016889A3 Dry powder formulation comprising a phosphodiesterase inhibitor |
| 04/19/2012 | WO2012013742A3 Stabilization of fsh |
| 04/19/2012 | WO2011163669A3 Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones |
| 04/19/2012 | WO2011161501A3 Solid compositions in form of powders or granulates for the oral administration of active ingredients and method for obtaining them |
| 04/19/2012 | WO2011161254A4 Swellable substance actuator with an electrically driven fluidic transportation device |
| 04/19/2012 | WO2011160098A3 Silk optical particles and uses thereof |
| 04/19/2012 | WO2011159871A3 Compositions and methods for the treatment of addiction, psychiatric disorders, and neurodegenerative disease |
| 04/19/2012 | WO2011156405A3 Oral spray formulations and methods for administration of sildenafil |
| 04/19/2012 | WO2011153334A3 Bioadhesive compositions for epithelial drug delivery |
| 04/19/2012 | WO2011153140A3 Antiperspirant compositions |
| 04/19/2012 | WO2011152692A3 Anti-obesity cream composition containing fucoxanthin |
| 04/19/2012 | WO2011152689A3 Method for purifying fucoxanthin derived from seaweed |
| 04/19/2012 | WO2011150127A3 Novel systems, vectors, and methods for delivery of biomolecules to eukaryotic cells |
| 04/19/2012 | WO2011149981A3 Oral formulations for counteracting effects of aging |
| 04/19/2012 | WO2011149288A3 Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases, and pharmaceutical composition containing same |
| 04/19/2012 | WO2011149206A3 Pharmaceutical composition containing crystalline nebivolol hydrochloride and method for preparing the same |
| 04/19/2012 | WO2011140203A3 Stabilized ophthalmic galactomannan formulations |
| 04/19/2012 | WO2011138797A3 Delayed release oral disintegrating pharmaceutical compositions of lansoprazole |
| 04/19/2012 | WO2011133566A3 Repairing bruch's membrane with hydrogels |
| 04/19/2012 | WO2011128783A3 Stable liquid oily ready-to-use formulations, preparation thereof and use thereof |
| 04/19/2012 | WO2011109384A3 Biodegradable polymers for lowering intraocular pressure |
| 04/19/2012 | WO2011104588A3 Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation |
| 04/19/2012 | WO2011104037A3 Process for preparing a ready-to-use product which can be metered |
| 04/19/2012 | WO2011101114A3 An inhalable pharmaceutical composition |
| 04/19/2012 | WO2011098285A3 Dermatological, pharmaceutical composition suitable for oligonucleotides |